Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
The appearance of multidrug resistance of pathogens is
challenging the researcher and industrial communities to develop more efficacious
antimicrobial treatments. Blue-O Technology Incorporation (Blue-O Tech) has developed
a novel formulation of medicine that accelerates the wound healing, while having an
excellent antimicrobial strength over a broad spectrum of pathogens. The objectives of
this study are to evaluate the cytotoxic effects, the immunological response, and the
healing properties of this novel medicine prior to its marketing and commercialization.
Horacio Bach
Blue-O Technology Inc.
Life Sciences
The University of British Columbia
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.